0001209191-19-002148.txt : 20190104
0001209191-19-002148.hdr.sgml : 20190104
20190104173325
ACCESSION NUMBER: 0001209191-19-002148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Jeff Marc
CENTRAL INDEX KEY: 0001703061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 19511267
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS
STREET 2: 55 CAMBRIDGE PARKWAY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-02
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001703061
Goldberg Jeff Marc
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Operating Officer
Common Stock
2019-01-01
4
J
0
493
21.5135
A
2880
D
Stock Option (right to buy)
30.73
2019-01-02
4
A
0
150000
0.00
A
2029-01-01
Common Stock
150000
150000
D
Although not required, the Reporting Person is voluntarily reporting the acquisition of 493 shares on January 1, 2019 pursuant to the Issuer's
Employee Stock Purchase Plan.
The shares vest as follows: 1/4th of the shares vest one year after January 2, 2019; 1/48th of the shares vest monthly thereafter over the next three years.
/s/ Paula Soteropoulos, Attorney-in-Fact
2019-01-04